{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:57:24Z","timestamp":1793372244202,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1038\/s41366-018-0080-7","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T14:08:17Z","timestamp":1528726097000},"page":"1151-1160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["FGF21 decreases body weight without reducing food intake or bone mineral density in high-fat fed obese rhesus macaque monkeys"],"prefix":"10.1038","volume":"42","author":[{"given":"Birgitte","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"Straarup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy M.","family":"Heppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Raffaele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Dissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00f3ra B.","family":"B\u00f6dvarsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Raun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin L.","family":"Grove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kievit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,11]]},"reference":[{"key":"80_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1507\/endocrj.KR07E-002","volume":"55","author":"S Fukumoto","year":"2008","unstructured":"Fukumoto S. Actions and mode of actions of FGF19 subfamily members. Endocr J. 2008;55:23\u201331.","journal-title":"Endocr J"},{"key":"80_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","volume":"78","author":"FM Fisher","year":"2016","unstructured":"Fisher FM, Maratos-Flier E. Understanding the physiology of FGF21. Annu Rev Physiol. 2016;78:223\u201341.","journal-title":"Annu Rev Physiol"},{"key":"80_CR3","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1210\/me.2010-0142","volume":"24","author":"K Fon Tacer","year":"2010","unstructured":"Fon Tacer K, Bookout AL, Ding X, Kurosu H, John GB, Wang L, et al. Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol Endocrinol. 2010;24:2050\u201364.","journal-title":"Mol Endocrinol"},{"key":"80_CR4","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.2337\/db14-0595","volume":"63","author":"KR Markan","year":"2014","unstructured":"Markan KR, Naber MC, Ameka MK, Anderegg MD, Mangelsdorf DJ, Kliewer SA, et al. Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding. Diabetes. 2014;63:4057\u201363.","journal-title":"Diabetes"},{"key":"80_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.molmet.2012.08.007","volume":"2","author":"AC Adams","year":"2012","unstructured":"Adams AC, Yang C, Coskun T, Cheng CC, Gimeno RE, Luo Y, et al. The breadth of FGF21\u2019s metabolic actions are governed by FGFR1 in adipose tissue. Mol Metab. 2012;2:31\u20137.","journal-title":"Mol Metab"},{"key":"80_CR6","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.3249","volume":"19","author":"AL Bookout","year":"2013","unstructured":"Bookout AL, de Groot MH, Owen BM, Lee S, Gautron L, Lawrence HL, et al. FGF21 regulates metabolism and circadian behavior by acting on the nervous system. Nat Med. 2013;19:1147\u201352.","journal-title":"Nat Med"},{"key":"80_CR7","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI23606","volume":"115","author":"A Kharitonenkov","year":"2005","unstructured":"Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, et al. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115:1627\u201335.","journal-title":"J Clin Invest"},{"key":"80_CR8","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1210\/en.2006-1168","volume":"148","author":"A Kharitonenkov","year":"2007","unstructured":"Kharitonenkov A, Wroblewski VJ, Koester A, Chen YF, Clutinger CK, Tigno XT, et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology. 2007;148:774\u201381.","journal-title":"Endocrinology"},{"key":"80_CR9","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1210\/en.2008-0816","volume":"149","author":"T Coskun","year":"2008","unstructured":"Coskun T, Bina HA, Schneider MA, Dunbar JD, Hu CC, Chen Y, et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology. 2008;149:6018\u201327.","journal-title":"Endocrinology"},{"key":"80_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","volume":"18","author":"G Gaich","year":"2013","unstructured":"Gaich G, Chien JY, Fu H, Glass LC, Deeg MA, Holland WL, et al. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab. 2013;18:333\u201340.","journal-title":"Cell Metab"},{"key":"80_CR11","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1210\/en.2012-1211","volume":"153","author":"MM Veniant","year":"2012","unstructured":"Veniant MM, Komorowski R, Chen P, Stanislaus S, Winters K, Hager T, et al. Long-acting FGF21 has enhanced efficacy in diet-induced obese mice and in obese rhesus monkeys. Endocrinology. 2012;153:4192\u2013203.","journal-title":"Endocrinology"},{"key":"80_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cmet.2016.02.001","volume":"23","author":"S Talukdar","year":"2016","unstructured":"Talukdar S, Zhou Y, Li D, Rossulek M, Dong J, Somayaji V, et al. A long-acting FGF21 molecule, PF-05231023, decreases body weight and improves lipid profile in non-human primates and type 2 diabetic subjects. Cell Metab. 2016;23:427\u201340.","journal-title":"Cell Metab"},{"key":"80_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2337\/db08-0392","volume":"58","author":"J Xu","year":"2009","unstructured":"Xu J, Lloyd DJ, Hale C, Stanislaus S, Chen M, Sivits G, et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes. 2009;58:250\u20139.","journal-title":"Diabetes"},{"key":"80_CR14","doi-asserted-by":"publisher","first-page":"e65763","DOI":"10.1371\/journal.pone.0065763","volume":"8","author":"AC Adams","year":"2013","unstructured":"Adams AC, Halstead CA, Hansen BC, Irizarry AR, Martin JA, Myers SR, et al. LY2405319, an engineered FGF21 variant, improves the metabolic status of diabetic monkeys. PLoS ONE. 2013;8:e65763.","journal-title":"PLoS ONE"},{"key":"80_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10928-016-9481-1","volume":"43","author":"WC Thompson","year":"2016","unstructured":"Thompson WC, Zhou Y, Talukdar S, Musante CJ. PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates. J Pharmacokinet Pharmacodyn. 2016;43:411\u201325.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"80_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cmet.2008.05.006","volume":"8","author":"T Inagaki","year":"2008","unstructured":"Inagaki T, Lin VY, Goetz R, Mohammadi M, Mangelsdorf DJ, Kliewer SA. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab. 2008;8:77\u201383.","journal-title":"Cell Metab"},{"key":"80_CR17","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1073\/pnas.1200797109","volume":"109","author":"W Wei","year":"2012","unstructured":"Wei W, Dutchak PA, Wang X, Ding X, Wang X, Bookout AL, et al. Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor gamma. Proc Natl Acad Sci USA. 2012;109:3143\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"80_CR18","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/nm.3250","volume":"19","author":"BM Owen","year":"2013","unstructured":"Owen BM, Bookout AL, Ding X, Lin VY, Atkin SD, Gautron L, et al. FGF21 contributes to neuroendocrine control of female reproduction. Nat Med. 2013;19:1153\u20136.","journal-title":"Nat Med"},{"key":"80_CR19","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cmet.2014.07.012","volume":"20","author":"BM Owen","year":"2014","unstructured":"Owen BM, Ding X, Morgan DA, Coate KC, Bookout AL, Rahmouni K, et al. FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss. Cell Metab. 2014;20:670\u20137.","journal-title":"Cell Metab"},{"key":"80_CR20","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.molmet.2016.05.010","volume":"5","author":"G Singhal","year":"2016","unstructured":"Singhal G, Douris N, Fish AJ, Zhang X, Adams AC, Flier JS, et al. Fibroblast growth factor 21 has no direct role in regulating fertility in female mice. Mol Metab. 2016;5:690\u20138.","journal-title":"Mol Metab"},{"key":"80_CR21","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2337\/db12-0598","volume":"62","author":"P Kievit","year":"2013","unstructured":"Kievit P, Halem H, Marks DL, Dong JZ, Glavas MM, Sinnayah P, et al. Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques. Diabetes. 2013;62:490\u20137.","journal-title":"Diabetes"},{"key":"80_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/ijo.2013.79","volume":"38","author":"EB Nygaard","year":"2014","unstructured":"Nygaard EB, Moller CL, Kievit P, Grove KL, Andersen B. Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta). Int J Obes. 2014;38:183\u201391.","journal-title":"Int J Obes"},{"key":"80_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.molmet.2012.11.001","volume":"2","author":"SM Comstock","year":"2012","unstructured":"Comstock SM, Pound LD, Bishop JM, Takahashi DL, Kostrba AM, Smith MS, et al. High-fat diet consumption during pregnancy and the early post-natal period leads to decreased alpha cell plasticity in the nonhuman primate. Mol Metab. 2012;2:10\u201322.","journal-title":"Mol Metab"},{"key":"80_CR24","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.","journal-title":"Nucleic Acids Res"},{"key":"80_CR25","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","volume":"17","author":"WL Holland","year":"2013","unstructured":"Holland WL, Adams AC, Brozinick JT, Bui HH, Miyauchi Y, Kusminski CM, et al. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab. 2013;17:790\u20137.","journal-title":"Cell Metab"},{"key":"80_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/387083a0","volume":"387","author":"AC McPherron","year":"1997","unstructured":"McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997;387:83\u201390.","journal-title":"Nature"},{"key":"80_CR27","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1210\/jc.2003-032047","volume":"89","author":"G Milan","year":"2004","unstructured":"Milan G, Dalla Nora E, Pilon C, Pagano C, Granzotto M, Manco M, et al. Changes in muscle myostatin expression in obese subjects after weight loss. J Clin Endocrinol Metab. 2004;89:2724\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"80_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1053\/j.gastro.2008.03.021","volume":"135","author":"A Kotronen","year":"2008","unstructured":"Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Jarvinen H. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology. 2008;135:122\u201330.","journal-title":"Gastroenterology"},{"key":"80_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0741-8329(89)90040-2","volume":"6","author":"NK Mello","year":"1989","unstructured":"Mello NK, Mendelson JH, Bree MP, Skupny A. Alcohol effects on LH and FSH in ovariectomized female monkeys. Alcohol. 1989;6:147\u201359.","journal-title":"Alcohol"},{"key":"80_CR30","doi-asserted-by":"publisher","unstructured":"Stanislaus S, Hecht R, Yie J, Hager T, Hall M, Spahr C, et al. A novel Fc FGF21 with improved resistance to proteolysis, increased affinity towards beta-Klotho and enhanced efficacy in mice and cynomolgus monkeys. Endocrinology. 2017;158:1314\u201327 \n                    https:\/\/doi.org\/10.1210\/en.2016-1917\n                    \n                  .","DOI":"10.1210\/en.2016-1917"},{"key":"80_CR31","doi-asserted-by":"publisher","first-page":"e73011","DOI":"10.1371\/journal.pone.0073011","volume":"8","author":"ES Muise","year":"2013","unstructured":"Muise ES, Souza S, Chi A, Tan Y, Zhao X, Liu F, et al. Downstream signaling pathways in mouse adipose tissues following acute in vivo administration of fibroblast growth factor 21. PLoS ONE. 2013;8:e73011.","journal-title":"PLoS ONE"},{"key":"80_CR32","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.celrep.2015.04.046","volume":"11","author":"RJ Samms","year":"2015","unstructured":"Samms RJ, Smith DP, Cheng CC, Antonellis PP, Perfield JW 2nd, Kharitonenkov A, et al. Discrete aspects of FGF21 in vivo pharmacology do not require UCP1. Cell Rep. 2015;11:991\u20139.","journal-title":"Cell Rep"},{"key":"80_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1101\/gad.177857.111","volume":"26","author":"FM Fisher","year":"2012","unstructured":"Fisher FM, Kleiner S, Douris N, Fox EC, Mepani RJ, Verdeguer F, et al. FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 2012;26:271\u201381.","journal-title":"Genes Dev"},{"key":"80_CR34","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1172\/JCI200113803","volume":"108","author":"LA Jesus de","year":"2001","unstructured":"de Jesus LA, Carvalho SD, Ribeiro MO, Schneider M, Kim SW, Harney JW, et al. The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J Clin Invest. 2001;108:1379\u201385.","journal-title":"J Clin Invest"},{"key":"80_CR35","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1210\/en.2014-2001","volume":"156","author":"N Douris","year":"2015","unstructured":"Douris N, Stevanovic DM, Fisher FM, Cisu TI, Chee MJ, Nguyen NL, et al. Central fibroblast growth factor 21 browns white fat via sympathetic action in male mice. Endocrinology. 2015;156:2470\u201381.","journal-title":"Endocrinology"},{"key":"80_CR36","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1210\/endo-110-5-1641","volume":"110","author":"HJ Quabbe","year":"1982","unstructured":"Quabbe HJ, Gregor M, Bumke-Vogt C, Hardel C. Pattern of plasma cortisol during the 24-hour sleep\/wake cycle in the rhesus monkey. Endocrinology. 1982;110:1641\u20136.","journal-title":"Endocrinology"},{"key":"80_CR37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1365-2826.2008.01800.x","volume":"21","author":"PW Czoty","year":"2009","unstructured":"Czoty PW, Gould RW, Nader MA. Relationship between social rank and cortisol and testosterone concentrations in male cynomolgus monkeys (Macaca fascicularis). J Neuroendocrinol. 2009;21:68\u201376.","journal-title":"J Neuroendocrinol"},{"key":"80_CR38","doi-asserted-by":"publisher","unstructured":"Li X, Stanislaus S, Asuncion F, Niu QT, Chinookoswong N, Villasenor K, et al. FGF21 Is not a major mediator for bone homeostasis or metabolic actions of PPARalpha and PPARgamma agonists. J Bone Miner Res. 2016;32:834\u201345 \n                    https:\/\/doi.org\/10.1002\/jbmr.2936\n                    \n                  .","DOI":"10.1002\/jbmr.2936"},{"key":"80_CR39","first-page":"2222","volume":"27","author":"R McKenzie","year":"2000","unstructured":"McKenzie R, Reynolds JC, O\u2019Fallon A, Dale J, Deloria M, Blackwelder W, et al. Decreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo controlled trial. J Rheumatol. 2000;27:2222\u20136.","journal-title":"J Rheumatol"},{"key":"80_CR40","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/ejcn.2011.212","volume":"66","author":"PS Hinton","year":"2012","unstructured":"Hinton PS, Rector RS, Linden MA, Warner SO, Dellsperger KC, Chockalingam A, et al. Weight-loss-associated changes in bone mineral density and bone turnover after partial weight regain with or without aerobic exercise in obese women. Eur J Clin Nutr. 2012;66:606\u201312.","journal-title":"Eur J Clin Nutr"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41366-018-0080-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41366-018-0080-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41366-018-0080-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:13:12Z","timestamp":1684617192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-018-0080-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["80"],"URL":"https:\/\/doi.org\/10.1038\/s41366-018-0080-7","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"28 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"BA, EMS, KMH, TBB, KR, KLG are employers and minor stock holders of Novo Nordisk A\/S. DLT, VR, GD, KL, and PK have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}